On the one hand, increased contents of resistin have been described in instances of both diet-induced obese and genetically-induced obesity while treatment of anti-resistin agent has been found to against high glucose level and to mitigate insulin resistance in experimental animals with obesity in prior studies [131]. Here, RETN is linked to obesity due to melanocortin 4 receptor deficiency.